{"id":31096,"date":"2020-07-10T10:07:13","date_gmt":"2020-07-10T08:07:13","guid":{"rendered":"https:\/\/fvz.upr.si\/?post_type=project&p=31096"},"modified":"2020-09-15T14:05:26","modified_gmt":"2020-09-15T12:05:26","slug":"j3-2277-combination-of-electrogene-immune-therapy-with-interleukin-12-and-irradition-for-treatment-of-experimental-tumors-basic-project-arrs","status":"publish","type":"project","link":"https:\/\/fvz.upr.si\/en\/project\/j3-2277-combination-of-electrogene-immune-therapy-with-interleukin-12-and-irradition-for-treatment-of-experimental-tumors-basic-project-arrs\/","title":{"rendered":"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS)"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.4.2″ background_enable_color=”off” background_image=”https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg” height=”330px” animation_style=”fade” custom_css_main_element=”padding-top: 0;||padding-bottom: 0;” saved_tabs=”all”][et_pb_row _builder_version=”3.27.2″ height=”100%” custom_css_main_element=”position: relative;||padding-top: 0;||padding-bottom: 0;”][et_pb_column type=”4_4″ _builder_version=”3.27.2″ custom_css_main_element=”height: 100%;”][et_pb_text _builder_version=”3.27.4″ _dynamic_attributes=”content” text_font=”Fira Sans|||on|||||” text_text_color=”#ffffff” text_font_size=”20px” custom_css_main_element=”background-color: #bf2f1a;||display: inline-block;||position: absolute;||bottom: 0;||padding: 16px;” border_width_all=”2px” border_color_all=”#821f22″ border_width_bottom=”0px”]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IiIsImFmdGVyIjoiIn19@[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”3.27.2″ background_color=”#f1f0ee” custom_padding=”60px||60px||false|false” custom_padding_tablet=”30px||30px||false|false” custom_padding_phone=”” animation_style=”fade” z_index_tablet=”500″ box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px”][et_pb_row _builder_version=”4.0.5″ width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” custom_margin=”|auto|60px|auto|false|false” custom_margin_tablet=”0px||0px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|desktop” custom_padding=”||||false|false” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.27.2″][et_pb_text _builder_version=”4.4.8″ text_font=”Fira Sans|700||on|||||” text_text_color=”#bf2e1b” text_font_size=”22px” header_font=”Arial|||on|||||” header_2_font=”||||||||” header_2_text_align=”left” header_2_font_size=”24px” custom_padding=”||||false|false”]<\/p>\n

Duration of the project:<\/strong><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.4.8″ custom_padding=”||0px|||”]<\/p>\n

1.5.2009 \u2013 30.4.2012<\/div>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.27.2″ width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” custom_margin=”-28px|auto||auto|false|false” custom_margin_tablet=”0px||0px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding=”||||false|false” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.27.2″][et_pb_text _builder_version=”4.4.2″ text_font=”Fira Sans|700||on|||||” text_text_color=”#bf2e1b” text_font_size=”22px” header_font=”Arial|||on|||||” header_2_font=”||||||||” header_2_text_align=”left” header_2_font_size=”24px” custom_padding=”||||false|false”]Projektni partnerji:[\/et_pb_text][et_pb_text _builder_version=”4.4.8″ custom_padding=”||0px|||”]<\/p>\n

University of Primorska Faculty of Health Sciences
Institute of Oncology Ljubljana<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.27.2″ width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” custom_margin=”30px|auto||auto|false|false” custom_margin_tablet=”0px||0px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding=”||||false|false” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.27.2″][et_pb_text _builder_version=”4.4.8″ text_font=”Fira Sans|700||on|||||” text_text_color=”#bf2e1b” text_font_size=”22px” header_font=”Arial|||on|||||” header_2_font=”||||||||” header_2_text_align=”left” header_2_font_size=”24px” custom_padding=”||||false|false”]<\/p>\n

Principal investigator \/ researcher:<\/strong><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.6.1″ custom_padding=”||0px|||” hover_enabled=”0″ sticky_enabled=”0″]<\/p>\n

Associate Prof. Maja \u010cema\u017ear, PhD\u00a0(SICRIS<\/a>, ResearchGate<\/a>)<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.27.2″ width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” custom_margin=”30px|auto||auto|false|false” custom_margin_tablet=”0px||0px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding=”||||false|false” locked=”off”][et_pb_column type=”4_4″ _builder_version=”3.27.2″][et_pb_text _builder_version=”4.4.8″ text_font=”Fira Sans|700||on|||||” text_text_color=”#bf2e1b” text_font_size=”22px” header_font=”Arial|||on|||||” header_2_font=”||||||||” header_2_text_align=”left” header_2_font_size=”24px” custom_padding=”||||false|false”]<\/p>\n

Link:<\/strong><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.4.8″ custom_padding=”||0px|||”]SICRIS<\/a><\/span>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.0.5″ width_tablet=”80%” width_phone=”” width_last_edited=”on|desktop” custom_margin=”30px|auto||auto|false|false” custom_margin_tablet=”0px||0px||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding=”||||false|false” locked=”off”][et_pb_column type=”4_4″ _builder_version=”4.0.5″][et_pb_text _builder_version=”4.4.8″ text_font=”Fira Sans|700||on|||||” text_text_color=”#bf2e1b” text_font_size=”22px” header_font=”Arial|||on|||||” header_2_font=”||||||||” header_2_text_align=”left” header_2_font_size=”24px” custom_padding=”||||false|false”]<\/p>\n

Background:<\/strong><\/p>\n

[\/et_pb_text][et_pb_text _builder_version=”4.4.8″ custom_padding=”||0px|||”]<\/p>\n

Electroporation is a physical method that uses electric pulses applied to cells or tissues to reorganize structure of the cell membrane. Cell membranes thus become permeable to molecules which otherwise can not cross it. Lately, electroporation is getting consideration also in gene therapy, where it is used as gene delivery method (electrogene therapy). In treatment of cancer, electrogene therapy can be used for electrotransfer of therapeutic genes directly to tumor or into other tissues for systemic release of therapeutic proteins acting on distant tumors. One of promising therapeutic genes that were already tested in electrogene therapy is interleukin-12 (IL-12). IL-12 stimulates innate immunity, by activating natural killer cells to produce interferon-g and adaptive immunity by stimulating differentiation of T lymphocytes Th1 response). In addition, IL-12 has also antiangiogenic properties. Combination of gene therapy with IL-12 for systemic release of IL-12 in combination with radiotherapy is a new field that has not been yet evaluated for treatment of cutaneous and subcutaneous as well as deeper seeded tumors. Therefore, our hypothesis is that electrotransfection of IL-12 into muscle using optimized parameters is efficient electrogene therapy that has therapeutic effect as single therapy and has radiosensitizing effect in combination with radiotherapy.<\/p>\n

Methods.
Measurements of in vitro cytotoxicity of recombinant IL-12 and testing of its radiosensitizing effect. In vivo transfection of tumors with electroporation and plasmid DNA encoding IL-12. Intratumoral and peritumoral application of electrogene therapy will be tested in solid subcutaneous tumors and antitumor effectiveness determined. In vivo transfection of muscles with plasmid DNA encoding IL-12 for systemic release of IL-12. Antitumor effectiveness in solid\u00a0subcutaneous tumors and lung metastases will be determined. Qualitative and quantitative analysis of transfection and expression of IL-12. Determination of antitumor effectiveness of systemic and local combined electrogene immune therapy with IL-12 and radiotherapy.<\/p>\n

Relevance and potential impact of the results.
The proposed project is designed as a preclinical project that involves experiments in cell cultures and animal and human tumor models. The results can contribute to the use of electrogene immunotherapy as an adjuvant therapy to radiotherapy. If successful, local potentiation of radiation response can lead to the use of lower irradiation doses and thus lower side effects. Combination of radiotherapy and systemic electrogene immunotherapy can in addition to enhanced local effect, result in systemic effect on micrometastases and has also prophylactic effect.<\/p>\n

\"\"<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Duration of the project:1.5.2009 \u2013 30.4.2012Projektni partnerji:University of Primorska Faculty of Health SciencesInstitute of Oncology LjubljanaPrincipal investigator \/ researcher:Associate Prof. Maja \u010cema\u017ear, PhD\u00a0(SICRIS, ResearchGate) Link:SICRISBackground:Electroporation is a physical method that […]<\/p>\n","protected":false},"author":12,"featured_media":29111,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"project_category":[144],"project_tag":[],"class_list":["post-31096","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-research-and-development-projects-completed"],"yoast_head":"\nJ3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju\" \/>\n<meta property=\"og:description\" content=\"Duration of the project:1.5.2009 \u2013 30.4.2012Projektni partnerji:University of Primorska Faculty of Health SciencesInstitute of Oncology LjubljanaPrincipal investigator \/ researcher:Associate Prof. Maja \u010cema\u017ear, PhD\u00a0(SICRIS, ResearchGate) Link:SICRISBackground:Electroporation is a physical method that […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/\" \/>\n<meta property=\"og:site_name\" content=\"Fakulteta za vede o zdravju\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-15T12:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"968\" \/>\n\t<meta property=\"og:image:height\" content=\"468\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/\",\"url\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/\",\"name\":\"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fvz.upr.si\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Raziskovanje-in-razvoj.jpg\",\"datePublished\":\"2020-07-10T08:07:13+00:00\",\"dateModified\":\"2020-09-15T12:05:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fvz.upr.si\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Raziskovanje-in-razvoj.jpg\",\"contentUrl\":\"https:\\\/\\\/fvz.upr.si\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Raziskovanje-in-razvoj.jpg\",\"width\":968,\"height\":468},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fvz.upr.si\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\\\/\\\/fvz.upr.si\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#website\",\"url\":\"https:\\\/\\\/fvz.upr.si\\\/\",\"name\":\"Fakulteta za vede o zdravju\",\"description\":\"\u017divljenju dodajamo znanje.\",\"publisher\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fvz.upr.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#organization\",\"name\":\"Fakulteta za vede o zdravju\",\"url\":\"https:\\\/\\\/fvz.upr.si\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fvz.upr.si\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/UP-FVZ_logo-transparent.png\",\"contentUrl\":\"https:\\\/\\\/fvz.upr.si\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/UP-FVZ_logo-transparent.png\",\"width\":1417,\"height\":792,\"caption\":\"Fakulteta za vede o zdravju\"},\"image\":{\"@id\":\"https:\\\/\\\/fvz.upr.si\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/","og_locale":"en_US","og_type":"article","og_title":"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju","og_description":"Duration of the project:1.5.2009 \u2013 30.4.2012Projektni partnerji:University of Primorska Faculty of Health SciencesInstitute of Oncology LjubljanaPrincipal investigator \/ researcher:Associate Prof. Maja \u010cema\u017ear, PhD\u00a0(SICRIS, ResearchGate) Link:SICRISBackground:Electroporation is a physical method that […]","og_url":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/","og_site_name":"Fakulteta za vede o zdravju","article_modified_time":"2020-09-15T12:05:26+00:00","og_image":[{"width":968,"height":468,"url":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/","url":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/","name":"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS) - Fakulteta za vede o zdravju","isPartOf":{"@id":"https:\/\/fvz.upr.si\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/#primaryimage"},"image":{"@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/#primaryimage"},"thumbnailUrl":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg","datePublished":"2020-07-10T08:07:13+00:00","dateModified":"2020-09-15T12:05:26+00:00","breadcrumb":{"@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/#primaryimage","url":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg","contentUrl":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2020\/04\/Raziskovanje-in-razvoj.jpg","width":968,"height":468},{"@type":"BreadcrumbList","@id":"https:\/\/fvz.upr.si\/project\/j3-2277-kombinacija-elektrogenske-imunske-terapije-z-interlevkinom-12-in-obsevanjem-za-zdravljenje-eksperimentalnih-tumorjev-temeljni-projekt-arrs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fvz.upr.si\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/fvz.upr.si\/project\/"},{"@type":"ListItem","position":3,"name":"J3-2277 Combination of Electrogene Immune Therapy with Interleukin-12 and Irradition for Treatment of Experimental Tumors (Basic project ARRS)"}]},{"@type":"WebSite","@id":"https:\/\/fvz.upr.si\/#website","url":"https:\/\/fvz.upr.si\/","name":"Fakulteta za vede o zdravju","description":"\u017divljenju dodajamo znanje.","publisher":{"@id":"https:\/\/fvz.upr.si\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fvz.upr.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fvz.upr.si\/#organization","name":"Fakulteta za vede o zdravju","url":"https:\/\/fvz.upr.si\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fvz.upr.si\/#\/schema\/logo\/image\/","url":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2019\/03\/UP-FVZ_logo-transparent.png","contentUrl":"https:\/\/fvz.upr.si\/wp-content\/uploads\/2019\/03\/UP-FVZ_logo-transparent.png","width":1417,"height":792,"caption":"Fakulteta za vede o zdravju"},"image":{"@id":"https:\/\/fvz.upr.si\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project\/31096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/comments?post=31096"}],"version-history":[{"count":3,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project\/31096\/revisions"}],"predecessor-version":[{"id":32802,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project\/31096\/revisions\/32802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/media\/29111"}],"wp:attachment":[{"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/media?parent=31096"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project_category?post=31096"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/fvz.upr.si\/en\/wp-json\/wp\/v2\/project_tag?post=31096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}